Tango Therapeutics(TNGX) - 2020 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 001-39485 85-1195036 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File Number) Identification No.) 12860 El Camino Real, Suite 300 San Diego, CA 92130 (Address of Principal Executive Offices) (Zip Code) (858) 400-3120 (Registrant's Telephone Number, Including Area Code) For the quarterly period ended S ...